4McAlister FA, Ezekowitz J, Hooton N, et al. Cardiac resynehronization therapy for patients with left ventricular systolic dysfunction : a systematic review [J]. JAMA, 2007, 297:2 502.
5Rivero-Ayerza M, Theuns D AMJ, Garcia-Garcia HM, et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials [ J ]. Eur Heart J, 2006,27:2 682.
6Daubert C, Gold MR, Abraham get, et al. Prevention of disease proton by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction insights from the European cohort of the REVERSE ( Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial[J]. J Am Col Cardiol, 2009,54:1 837.
7Carson P, Anand I, O'Connor C, et al. Mode of death in advanced heart failure the Comparison of medical, pacing, and defibrillation therapies in heart failure (COMPANION) trial[ J]. J Am Call Cardiol, 2005,46:2 329.
8Bradley DJ, Bradley EA, Baughman KL,et al. Cardiac resynehronization and death from progressive heart failure: a meta-analysis of madomized controlled triais[J]. JAMA, 2003,289:730.
9Bai R, BiaseI LD, Eiayi C, et al. Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors [J]. J Cardiovasc Electrophysiol, 2008, 19:1 259.
10Cleland JGF, Daubert JC, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [ the Cardiac Resynchronization-Heart Failure (CABE-HF) trial extension phase] [J]. Eur Heart J, 2006, 27:1 928.
